Article info

Download PDFPDF

Patient perception of voxelotor treatment benefit in sickle cell disease

Authors

  • Modupe Idowu Department of Internal Medicine, The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Anam Haque The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Elisa M Williams The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Arthi Sridhar Department of Internal Medicine, The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, Texas, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Modupe Idowu, Department of Internal Medicine, The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, TX 77030, USA; modupe.idowu{at}uth.tmc.edu
View Full Text

Citation

Idowu M, Haque A, Williams EM, et al
Patient perception of voxelotor treatment benefit in sickle cell disease

Publication history

  • Accepted April 1, 2022
  • First published June 22, 2022.
Online issue publication 
June 22, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.